CTXR

Citius Pharmaceuticals, Inc. CTXR

CTXR
Citius Pharmaceuticals, Inc. ATHA
Athira Pharma, Inc. LPTX
Leap Therapeutics, Inc. ICU
SeaStar Medical Holding Corporation APLM
Apollomics, Inc. CRIS
Curis, Inc. ADTX
Aditxt, Inc. MBRX
Moleculin Biotech, Inc. FBLG
FibroBiologics, Inc. Common Stock LNAI
Lunai Bioworks Inc.

Résultat net

EBITDA

P/E Ratio

Capitalisation

Performance

Periode CTXR ATHA LPTX ICU APLM CRIS ADTX MBRX FBLG LNAI
6M -33.28 % 131.09 % 314.45 % -42.79 % 196.38 % -51.61 % -99.38 % -47.01 % -67.25 % -56.75 %
YTD -79.37 % 31.09 % -63.66 % -87.59 % 66.57 % -75.24 % -99.98 % -91.19 % -88.15 % -56.75 %
1Y -75.81 % 33.77 % -60.74 % -88.42 % 71.50 % -66.56 % -99.98 % -91.19 % -89.79 % -56.75 %
3Y -96.02 % -75.81 % -72.98 % -99.77 % -98.26 % -88.83 % -100.00 % -99.06 % -99.19 % -56.75 %
5Y -97.01 % -97.74 % -94.71 % -99.91 % -98.18 % -99.33 % -100.00 % -99.81 % -99.19 % -56.75 %
10Y -99.88 % -95.79 % -98.51 % -99.91 % -98.18 % -99.63 % -100.00 % -99.98 % -99.19 % -56.75 %
Depuis le début -99.79 % -95.79 % -98.51 % -99.91 % -98.18 % -99.96 % -100.00 % -99.98 % -99.19 % -56.75 %

Dividende